What is the latest published MO stock rating?

Altria Group, Inc. is shown with Reduce in the latest published report, analyzed 2026-10-18. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full MO analysis?

The full latest published report, analyzed 2026-10-18, lives at /stocks/MO/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair value is used for MO?

The latest published report analyzed 2026-10-18 gives MO a fair value of USD 62 and a potential value of USD 85. These are dated research outputs, not live market prices; review the valuation assumptions, sensitivity analysis, and material risks before making a decision.

How often is the MO page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-10-18). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

MO Stock: Fundamentals & Analysis | StockMarketAgent.AI

Se connecter Start free

Altria Group, Inc. (MO)

NYSE: MO · USD

—

StockMarketAgent Research · Analyzed 2026-10-18

Our latest published analysis: MO rated Reduce

Altria Group, Inc.'s published Reduce conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.

Fair value

$61.6 / share

Potential value

$84.6 / share

Upside to FV

-18.0%

Moat

7.5/10

Narrow

Read full analysis →View archive · 24mo

9-phase methodology · same model in each published edition

Market cap	$125.4B
P/E (forward)	11.9x

Market data

Price

Recent price action with selectable time range.

Financial snapshot

P/E (forward): 11.9x
Market cap: $125.4B

Item	P1	P2	P3	P4	P5	Trend
Period	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31	Trend
Revenue	$26.01B	$25.10B	$24.48B	$24.02B	$23.28B	-2.7%
Gross profit	$13.99B	$14.25B	$14.28B	$14.37B	$14.54B	+1.0%
Operating income	$11.56B	$11.92B	$11.55B	$11.24B	$9.90B	-3.8%
Net income	$2.48B	$5.76B	$8.13B	$11.26B	$6.95B	+29.4%
EPS (diluted)	$1.34	$3.19	$4.57	$6.54	$4.12	+32.4%
EBITDA	$5.26B	$8.74B	$12.32B	$15.07B	$10.83B	+19.8%
R&D	$145.0M	$162.0M	$220.0M	$208.0M	$195.0M	+7.7%
SG&A	$2.43B	$2.33B	$2.77B	$214.0M	$2.26B	-1.8%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
BA	The Boeing Company	—	—	—	—	—	—	Vendre
BMY	Bristol-Myers Squibb Company	—	—	—	—	—	—	Vendre
CHTR	Charter Communications, Inc.	—	—	—	—	—	—	Achat fort
ADM	Archer-Daniels-Midland Company	—	—	—	—	—	—	Réduire
BF.B	Brown-Forman Corporation Class B	—	—	—	—	—	—	Acheter
CAG	Conagra Brands, Inc.	—	—	—	—	—	—	Achat fort

Base and Bull scenarios

Base55%

Price target

$61.61

-18.0% from spot

The Base scenario reflects the modal operating path: combustible volume secular decline is successfully mitigated by disciplined, continuous price realization. Marlboro maintains premium dominance while discount brands like Basic capture trade-down smokers. Smoke-free progress is modest, with on! growing absolute volume but losing pouch category share to dominant competitors, and NJOY remaining sidelined. Operating cash flow remains robust around $9.0B-$9.5B, enabling steady dividend payments ($4.44 per share) and modest share buybacks. However, with market price ($75.11) exceeding mid fair value ($61.61), investor returns are constrained.

Underlying domestic cigarette volume declines persist at -4.0% to -4.5% annually
Marlboro price increases of 5.5% to 6.5% offset volume declines, stabilizing Smokeable OCI near $10.5B to $11.0B
Consolidated operating margin stabilizes between 42.6% and 43.2%
on! pouch category share holds near 14% to 15% while MST volumes contract ~10% annually
CapEx remains low at $300M to $450M annually
Cost of capital moderate Ke remains at 7.46% and WACC at 6.97%

Bull20%

Price target

$84.57

+12.6% from spot

In the Bull scenario, adult consumer discretionary income recovers, curtailing discount trade-down. Regulatory enforcement against illicit disposable vapes redirects nicotine volume back into Marlboro and authorized oral nicotine pouches. Helix's national rollout of on! PLUS across 120,000 stores scales rapidly, turning the smoke-free segment into an accretive profit driver. Altria's FCF generation comfortably supports annual dividend increases and >$1B in annual share repurchases, justifying valuation near the top of the fair value range ($84.57).

Combustible cigarette volume declines moderate significantly from historical contraction rates.
Marlboro maintains dominant premium category share while sustaining strong annual pricing realization.
Modern oral products on! and on! PLUS capture expanding share of the nicotine pouch market.
FDA PMTA enforcement successfully eliminates illicit disposable vapes from retail shelves
Consolidated operating margin expands through smokeable pricing realization and supply chain efficiency.
Annual earnings per share growth accelerates above historical trend lines driven by share repurchases and margin expansion.

Sensitivity: Ke × terminal growth

The highlighted cell is Fair value when every assumption sits at its base level ($61.61). Each row and column shows what Fair value becomes when one assumption moves.

Ke ↓ / g →	1.0%	1.3%	1.5%	1.8%	2.0%
6.5%	$66.7	$68.5	$70.4	$72.7	$75.2
7.0%	$62.6	$64.0	$65.6	$67.3	$69.3
7.5%	$59.2	$60.4	$61.6	$63.0	$64.5
8.0%	$56.2	$57.2	$58.3	$59.4	$60.6
8.5%	$53.7	$54.5	$55.4	$56.3	$57.3

Scorecard

Published factor rows and weighted composite

Valuation3.0

Management6.5

Balance Sheet3.0

Profitability6.5

Revenue Growth4.5

Risk Assessment5.5

Competitive Moat7.5

Earnings Quality7.5

Capital Efficiency8.5

Weighted composite

5.8/10

Mixed

Category	Score	Reading
Valuation	3.0
Management	6.5
Balance Sheet	3.0
Profitability	6.5
Revenue Growth	4.5
Risk Assessment	5.5
Competitive Moat	7.5
Earnings Quality	7.5
Capital Efficiency	8.5

Historique des notations

La notation portée par l'édition de recherche publiée chaque mois. Une notation compare le cours à la date d'analyse à la juste valeur ; elle n'indique pas si l'appréciation s'est révélée juste.

Année	janv.	févr.	mars	avr.	mai	juin	juil.	août	sept.	oct.	nov.	déc.
2026

Altria Group, Inc. (MO)

Our latest published analysis: MO rated Reduce

Price

Financial snapshot

Fair-value bridge

Latest news · MO

Valuation

Base and Bull scenarios

Sensitivity: Ke × terminal growth

Scorecard

Next earnings

Sector percentile context

Deeper analysis on MO

Frequently asked questions

Historique des notations